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Abstract
Heart disease continues to be the leading cause of death in the United States.
Humans are unable to regenerate their heart tissue following an injury.
However, neonatal mice are able to regenerate their heart tissue when
cardiomyocytes (CMs) proliferate. This regenerative ability is lost
approximately one week after birth when proliferating mononucleated CMs
become binucleated and can no longer complete the cell-cycle. Recent
studies have shown the combined inhibition of thyroid hormone (T3) and
norepinephrine (NE) increases CM proliferation, promotes heart
regeneration, and reduces cell size in vivo. Using digital holographic
microscopy, the aim of this study was to (1) validate the novel Halomonitor
approach and (2) visualize and quantify the effects of T3 and NE on
cardiomyocyte size. CMs were isolated from neonatal rats 1 to 2 days after
birth which were then treated with NE and/or T3 in serum-free culture. Live
cell imaging was visualized utilizing digital holographic microscopy and
changes in CM dynamics and morphology were quantitatively tracked and
analyzed using HoloMonitor software. The results from this study validate
the HoloMonitor technology by demonstrating that NE induced
hypertrophy in CMs after 12 hours. Our results also demonstrate the ability
of HaloMonitor technology to differentiate between CMs and non-CMs in
living, serum-free culture, while also studying and quantifying their
dynamics in vitro. Lastly, our data shows that T3 has little effect on CM
growth and that NE decreased CM motility.
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Introduction
Heart disease plagues the United States and continues to be the
leading cause of death for Americans (CDC, 2022). Damage to heart tissue
is especially detrimental to one's health due to its inability to regenerate;
thus, patients are left with a weaker heart for the rest of their lives. However,
this lack of cardiac regenerative ability is not universal to all animals.
Unlike adult mammals, which have a limited capacity to regenerate
their hearts after injury, newborn rodents are capable of cardiac tissue
regeneration. Such regeneration relies on the proliferation of heart muscle
cells called cardiomyocytes (CMs) (Porrello et al, 2011). Mice lose the
ability to regenerate their heart tissue within the first week after birth when
CMs transition from proliferating mononucleated cells to binucleated cells
which are incapable of completing the cell cycle (Soonpa et al, 1996).
Following this transition of mononucleated to binucleated CMs,
hypertrophy is the cause for increased heart mass.
It is known that inhibition of thyroid hormone (TH) and adrenergic
receptor (AR) signaling in postnatal mice CMs causes them to not
binucleate and not exit the cell cycle; therefore, the cell can regenerate.
Conversely, although the cellular mechanism is unknown, it has been
established that the synergistic activation of both TH and AR signaling will
prevent cardiomyocyte proliferation in vivo (Payumo and Chen et al, 2021).
It is known that norepinephrine (NE), a hormone that binds to adrenergic
receptors, induces CM hypertrophy. However, little is known about the
synergistic activation of TH and AR signaling on cardiomyocyte size. We
suspect that T3 and NE signaling activation will promote hypertrophic
growth in CMs.
Using digital holographic microscopy, the goal of this research is to
quantitatively visualize the hormonal effects of activated T3 and NE
signaling in newborn mice CMs (in vitro) pertaining to hypertrophic growth
dynamics. Specifically, we aim to determine if T3 and NE signaling
interactions promote cardiomyocyte hypertrophy.
Because the cellular mechanism of cardiomyocyte proliferation is
unknown, this research aims to help answer the question: “Does
cardiomyocyte hypertrophy effect proliferation?” Answering this question
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will better inform efforts moving forward to identify the mechanism of CM
proliferation. This will have a monumental impact on the future of cardiac
regenerative medicine.
Methods
Schematic of Experimental Approach:
First,
cardiomyocytes
were
collected from newborn mice 1-2
days after birth. The CMs were
then treated with the thyroid
hormone triiodothyronine (T3) and
norepinephrine (NE) in vitro in
serum-free culture. The CMs in
this study were divided into 4 test
groups: (1) control group,
receiving no hormone treatment,
(2) the T3 treated group, (3) the NE
treated group, and (4) the T3 + NE
treated group.
After treatment, the CMs were
visualized via digital holographic
microscopy, HoloMonitor® live
cell imaging microscope. Timelapse movies of live CMs were
acquired with 3D and single-cell
resolution. CM changes in
dynamics and morphology were
visually and quantitatively tracked
and analyzed using HoloMonitor®
software.
Significance
was
determined by Student’s t-test and one-way ANOVA.
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Results
Cardiomyocytes were able to be distinguished from noncardiomyocytes (Figure 1) by analyzing optical volume (morphology) and
the distance traveled (motility) of cells over the span of 4 hours. CMs were
identified by being larger and slower than the non-CMs, which were smaller
and had an increase in motility.
Figure 1: Label-free cardiomyocytes are distinguished from noncardiomyocytes by size and motility.

Figure 1. Cardiomyocytes (CM) were distinguished from non-CMs based
on cellular morphology and motility. (A) Representative image showing a
non-CM (yellow arrowhead) surrounded by CMs (white arrowhead). NonCMs tend to be smaller. (B) Quantification of optical volume of CMs
(n=10) and Non-CMs (n=5) at 4 hours. ***p<0.001 (C) Total distance
traveled of CMs and Non-CMs at 4 hours after treatment. ****p<0.0001
determined by Student’s t-test. Segmentation thresholds differ from those
used in Figures 2 and 3.
T3 treatment does not have a significant effect on CM size as it is
both visually and qualitatively similar to the control. The only significant
increase in average optical volume is shown in the NE and NE+T3 treated
CMs, with the NE treated having the largest.
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Figure 2: Digital holographic microscopy allows real-time monitoring of
hypertrophic growth dynamics.

Figure 2. (A) Frames from a time-lapse movie tracking changes in
cardiomyocyte (CM) optical volumes over a 24-hour period. Examples of
a control CM (top), and a CM treated with norepinephrine (NE) (bottom)
are shown. (B) Normalized average optical volumes of CMs in control
conditions (gray, n=100), treated with NE (blue. n=100), treated with
thyroid hormone (T3) (red, n=100), and treated with NE + T3 (green,
n=100). *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 determined by
one-way ANOVA. All cells normalized to average starting volumes at 0
hours for each respective treatment. Segmentation thresholds were identical
to those used in Figure 3.
46-hour end point analysis showed that T3 did not have a significant
impact on CM optical volume compared to the control. NE treated CM were
visually larger in size than the control, showing that NE does induce CM
hypertrophy after 46 hours (expected). The T3 + NE treated CM is visually
larger than the control after 46 hours, but on average are not significantly
different from the NE treated cells.
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Figure 3: Norepinephrine promotes hypertrophic growth while thyroid
hormones have little effect after 46 hours.

Figure 3. (A) Representative images of cardiomyocytes (CMs) treated with
norepinephrine (NE) and/or thyroid hormone (TH) for 46 hours. Control
conditions (upper left), after NE treatment (upper right), after T3 treatment
(bottom left), and N + T3 treatment (bottom right). (B) Raw optical volumes
of CMs after 46 hours in control condition (gray, n=100), after NE treatment
(red. n=100), after T3 treatment (blue, n=100), and NE + T3 treatment
(green, n=100). ****p<0.0001 determined by one-way ANOVA.
Segmentation thresholds were identical to those used in Figure 2.
The motility of CMs were tracked over 24 hours. The control and
T3 treated CMs did not experience a significant change in motility.
However, the motility (average distance traveled) of NE and NE + T3
treated CMs significantly decreased over 24 hours.
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Figure 4: An unexpected role for norepinephrine in cardiomyocyte motility
regulation.
Figure
4.
Norepinephrine
(NE) decreases in
CM motility. (A)
Spatial
tracking
plots of CMs in
control conditions
(top, n=10) and CMs
after treatment of
NE (bottom, n=10)
over 24 hours. (B)
Average
distance
traveled after 24
hours of CMs in
control
condition
(gray, n=50), NE treatment (blue, n=50), T3 treatment (red, n=50), and NE
+ T3 treatment (green, n=50).
Discussion
Data obtained from Figure 1 allowed us to distinguish between CM
and non-CMs in unfixed living tissue samples in real-time. This was crucial
to the study as there appeared to be different types of cells found in cardiac
tissue other than CMs.
Data from Figure 2 showed that T3 treatment does not have a
significant effect on CM size and that the only significant increase in
average optical volume was with the NE-treated CMs. Because we know
that NE induces hypertrophy, this data validates the use of the novel
HoloMonitor® live cell imaging microscope. The benefits of this
technology include 3D visualization and quanti-fication of living cells.
Tissue integrity is upheld due to the ability to visualize the cells without
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labels or stains/dyes. Additionally, the same sample can be used for
different assays and quantifications, thus saving laboratory resources (PHI,
n.d.).
The 46-hour end point analysis (Figure 3) allowed us to visually and
qualitatively show that the control and T3-treated CMs appear the same in
size, indicating that T3 did not have a significant impact on CM optical
volume after 46 hours. As expected, visually, NE-treated CMs were larger
in size than the control, showing that NE does induce CM hypertrophy. The
T3 + NE-treated CM is confirmed to also be visually larger than the control,
but not significantly different from the NE-treated cells, indicating that T3
does not have a significant impact on CM hypertrophy.
Motility analysis showed that NE-treated CMs experience a
decrease in average distance traveled over 24 hours. This was an unexpected
finding; thus, the effect of NE-induced motility inhibition in CMs should be
investigated in future studies as both proliferation and migration are
required for heart regeneration.
Though this study answered some questions about CM dynamics,
more research needs to be done to truly answer the question: Does size
matter? It is our hope that future studies will build upon the data obtained
from this study to further investigate if/how hormone-induced hypertrophy
affects cell cycle activity.
Conclusion
Holographic microscopy is a novel approach to study living, labelfree cardiomyocyte (CM) dynamics in vitro in real-time and is also able to
distinguish CMs from non-CMs. Validation of this technology was
achieved by showing that NE induces hypertrophy in CMs over time. We
also showed that NE suppressed CM motility, which was unexpected.
Lastly, our results also show that T3 treatment had little effect on CM
hypertrophic growth dynamics.
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